Article
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
Respiratory research - 27 Apr 2021
Pratte Katherine A, Curtis Jeffrey L, Kechris Katerina, Couper David, Cho Michael H, Silverman Edwin K, DeMeo Dawn L, Sciurba Frank C, Zhang Yingze, Ortega Victor E, O'Neal Wanda K, Gillenwater Lucas A, Lynch David A, Hoffman Eric A, Newell John D, Comellas Alejandro P, Castaldi Peter J, Miller Bruce E, Pouwels Simon D, Hacken Nick H T Ten, Bischoff Rainer, Klont Frank, Woodruff Prescott G, Paine Robert, Barr R Graham, Hoidal John, Doerschuk Claire M, Charbonnier Jean-Paul, Sung Ruby, Locantore Nicholas, Yonchuk John G, Jacobson Sean, Tal-Singer Ruth, Merrill Debbie, Bowler Russell P
Abstract excerpt
BACKGROUND: Soluble receptor for advanced glycation end products (sRAGE) is a proposed emphysema and airflow obstruction biomarker; however, previous publications have shown inconsistent associations and only one study has investigate the association between sRAGE and emphysema. No cohorts have examined the association between sRAGE and progressive decline of lung function. There have also been no evaluation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.